Track record · closed signal

Doximity, Inc. (DOCS) — closed signal from November 22, 2025

Partial Published before the outcome was known, scored automatically when the window closed on February 20, 2026.

Predicted vs. what happened

DOCS price · publication thesis → realized outcomesplit-adjusted
$50.42 Published $69.58 Target $25.55 Window close $51.85 Peak
$48.00 – $52.00Entry zone — fair-value band
$50.42Published — price the day we called it
$69.58Target — the price the thesis aimed for
$51.85Peak — highest point inside the window, not a realized return
$25.55Window close — end-of-window price, context only

What happened

Partial

Reached 7% of the predicted growth at its peak, without hitting the target.

Peak price
$51.85
peak on November 28, 2025 — not a realized return
Peak gain
+2.8%
peak, from the publication price
Window close
$25.55
end-of-window price, context only
Days to target
Window
November 22, 2025 – February 20, 2026

The thesis — published November 22, 2025

Predicted growth
+38%
over the measurement window
Target price
$69.58
the price the thesis aimed for
Entry zone
$48.00 – $52.00
the fair-value band we waited for
Price at publication
$50.42
published November 22, 2025
Confidence
68%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Doximity is a profitable digital health company that recently pulled back a lot from its highs. The price is below its recent average and some short-term measures are moving back from very low levels. Overall investor sentiment is strong and the business fundamentals look healthy, so this looks like a short-term bounce if sales and margins stay steady.

Primary drivers

  • Large network of doctors and useful workflow tools, profitable model.
  • Price dropped after a strong run and is below recent averages.
  • Investors feel very positive and fundamentals remain solid.
  • Upside relies on continued growth and no bad earnings surprises.

How it played out

DOCS: the short-term bounce did not reach the target

Lyra published DOCS on 2025-11-22 at 50.42. The thesis looked for 38% growth in a short-term window. It pointed to Doximity's large doctor network, workflow tools, profitable model, a pullback below recent averages, positive investor sentiment, and solid fundamentals. The setup depended on continued growth and no bad earnings surprises.

Inside the window, DOCS rose only to 51.85 on 2025-11-28, a 2.8% peak gain. It stayed below the 69.58 target and never reached it. By 2026-02-20, it ended at 25.55. The published bounce thesis missed.

What happened during the window

On 2026-02-05, Doximity reported fiscal 2026 third quarter results, with revenue of $185.1 million and net income of $61.6 million. The same release said the board authorized another stock repurchase program of up to $500 million.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.